Literature DB >> 21807898

Antagonistic regulation of cystic fibrosis transmembrane conductance regulator cell surface expression by protein kinases WNK4 and spleen tyrosine kinase.

Ana Isabel Mendes1, Paulo Matos, Sónia Moniz, Simão Luz, Margarida D Amaral, Carlos M Farinha, Peter Jordan.   

Abstract

Members of the WNK (with-no-lysine [K]) subfamily of protein kinases regulate various ion channels involved in sodium, potassium, and chloride homeostasis by either inducing their phosphorylation or regulating the number of channel proteins expressed at the cell surface. Here, we describe findings demonstrating that the cell surface expression of the cystic fibrosis transmembrane conductance regulator (CFTR) is also regulated by WNK4 in mammalian cells. This effect of WNK4 is independent of the presence of kinase and involves interaction with and inhibition of spleen tyrosine kinase (Syk), which phosphorylates Tyr512 in the first nucleotide-binding domain 1 (NBD1) of CFTR. Transfection of catalytically active Syk into CFTR-expressing baby hamster kidney cells reduces the cell surface expression of CFTR, whereas that of WNK4 promotes it. This is shown by biotinylation of cell surface proteins, immunofluorescence microscopy, and functional efflux assays. Mutation of Tyr512 to either glutamic acid or phenylalanine is sufficient to alter CFTR surface levels. In human airway epithelial cells, downregulation of endogenous Syk and WNK4 confirms their roles as physiologic regulators of CFTR surface expression. Together, our results show that Tyr512 phosphorylation is a novel signal regulating the prevalence of CFTR at the cell surface and that WNK4 and Syk perform an antagonistic role in this process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807898      PMCID: PMC3187369          DOI: 10.1128/MCB.05152-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  WNK kinases regulate thiazide-sensitive Na-Cl cotransport.

Authors:  Chao-Ling Yang; Jordan Angell; Rose Mitchell; David H Ellison
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion.

Authors:  Kristopher T Kahle; Frederick H Wilson; Qiang Leng; Maria D Lalioti; Anthony D O'Connell; Ke Dong; Alicia K Rapson; Gordon G MacGregor; Gerhard Giebisch; Steven C Hebert; Richard P Lifton
Journal:  Nat Genet       Date:  2003-11-09       Impact factor: 38.330

3.  WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia.

Authors:  Kristopher T Kahle; Ignacio Gimenez; Hatim Hassan; Frederick H Wilson; Robert D Wong; Biff Forbush; Peter S Aronson; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

4.  Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways.

Authors:  N Matter; M Marx; S Weg-Remers; H Ponta; P Herrlich; H König
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

5.  WNK kinases, a novel protein kinase subfamily in multi-cellular organisms.

Authors:  F Veríssimo; P Jordan
Journal:  Oncogene       Date:  2001-09-06       Impact factor: 9.867

6.  CFTR regulation by phosphorylation.

Authors:  Rodrigo Alzamora; J Darwin King; Kenneth R Hallows
Journal:  Methods Mol Biol       Date:  2011

7.  A comparison of 14 antibodies for the biochemical detection of the cystic fibrosis transmembrane conductance regulator protein.

Authors:  Carlos M Farinha; Filipa Mendes; Mónica Roxo-Rosa; Deborah Penque; Margarida D Amaral
Journal:  Mol Cell Probes       Date:  2004-08       Impact factor: 2.365

8.  Development of a colorimetric method for functional chloride channel assay.

Authors:  Weimin Tang; Mary Jo Wildey
Journal:  J Biomol Screen       Date:  2004-10

9.  Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4.

Authors:  Frederick H Wilson; Kristopher T Kahle; Ernesto Sabath; Maria D Lalioti; Alicia K Rapson; Robert S Hoover; Steven C Hebert; Gerardo Gamba; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-06       Impact factor: 11.205

10.  Unusually common cystic fibrosis mutation in Portugal encodes a misprocessed protein.

Authors:  Filipa Mendes; Mónica Roxo Rosa; Anca Dragomir; Carlos M Farinha; Godfried M Roomans; Margarida D Amaral; Deborah Penque
Journal:  Biochem Biophys Res Commun       Date:  2003-11-21       Impact factor: 3.575

View more
  18 in total

1.  Contribution of casein kinase 2 and spleen tyrosine kinase to CFTR trafficking and protein kinase A-induced activity.

Authors:  Simão Luz; Patthara Kongsuphol; Ana Isabel Mendes; Francisco Romeiras; Marisa Sousa; Rainer Schreiber; Paulo Matos; Peter Jordan; Anil Mehta; Margarida D Amaral; Karl Kunzelmann; Carlos M Farinha
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

2.  A "SYDE" effect of hierarchical phosphorylation: possible relevance to the cystic fibrosis basic defect.

Authors:  A Venerando; L Cesaro; O Marin; A Donella-Deana; L A Pinna
Journal:  Cell Mol Life Sci       Date:  2014-02-25       Impact factor: 9.261

3.  Proteomic interaction profiling reveals KIFC1 as a factor involved in early targeting of F508del-CFTR to degradation.

Authors:  Sara Canato; João D Santos; Ana S Carvalho; Kerman Aloria; Margarida D Amaral; Rune Matthiesen; André O Falcao; Carlos M Farinha
Journal:  Cell Mol Life Sci       Date:  2018-07-31       Impact factor: 9.261

Review 4.  Trafficking and function of the cystic fibrosis transmembrane conductance regulator: a complex network of posttranslational modifications.

Authors:  Michelle L McClure; Stephen Barnes; Jeffrey L Brodsky; Eric J Sorscher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-29       Impact factor: 5.464

Review 5.  Molecular mechanisms of cystic fibrosis - how mutations lead to misfunction and guide therapy.

Authors:  Carlos M Farinha; Isabelle Callebaut
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

Review 6.  One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.

Authors:  Marjolein M Ensinck; Marianne S Carlon
Journal:  Cells       Date:  2022-06-08       Impact factor: 7.666

Review 7.  From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking.

Authors:  Carlos M Farinha; Sara Canato
Journal:  Cell Mol Life Sci       Date:  2016-10-03       Impact factor: 9.261

Review 8.  Pharmacological targeting of SPAK kinase in disorders of impaired epithelial transport.

Authors:  Jinwei Zhang; Jason K Karimy; Eric Delpire; Kristopher T Kahle
Journal:  Expert Opin Ther Targets       Date:  2017-07-12       Impact factor: 6.902

Review 9.  WNK4 kinase: from structure to physiology.

Authors:  Adrián Rafael Murillo-de-Ozores; Alejandro Rodríguez-Gama; Héctor Carbajal-Contreras; Gerardo Gamba; María Castañeda-Bueno
Journal:  Am J Physiol Renal Physiol       Date:  2021-01-25

Review 10.  CCT and CCT-Like Modular Protein Interaction Domains in WNK Signaling.

Authors:  Clinton A Taylor; Melanie H Cobb
Journal:  Mol Pharmacol       Date:  2021-07-26       Impact factor: 4.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.